A detailed history of Urban Wealth Management, LLC transactions in Outlook Therapeutics, Inc. stock. As of the latest transaction made, Urban Wealth Management, LLC holds 7,473 shares of OTLK stock, worth $42,895. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,473
Holding current value
$42,895
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$0.91 - $2.01 $6,800 - $15,020
7,473 New
7,473 $8,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.3B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Urban Wealth Management, LLC Portfolio

Follow Urban Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Urban Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Urban Wealth Management, LLC with notifications on news.